192 related articles for article (PubMed ID: 9231199)
21. Microfilariae of Wuchereria bancrofti in urine: an uncommon finding.
Verma R; Vij M
Diagn Cytopathol; 2011 Nov; 39(11):847-8. PubMed ID: 21994197
[TBL] [Abstract][Full Text] [Related]
22. The effects of diethylcarbamazine on the ultrastructure of microfilariae of Wuchereria bancrofti.
Florêncio MS; Peixoto CA
Parasitology; 2003 Jun; 126(Pt 6):551-4. PubMed ID: 12866792
[TBL] [Abstract][Full Text] [Related]
23. Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after start of treatment.
Meyrowitsch DW; Simonsen PE; Makunde WH
Trans R Soc Trop Med Hyg; 1996; 90(4):423-8. PubMed ID: 8882196
[TBL] [Abstract][Full Text] [Related]
24. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand.
Koyadun S; Bhumiratana A; Prikchu P
Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084
[TBL] [Abstract][Full Text] [Related]
25. Treatment of microfilaraemia in asymptomatic brugian filariasis: the efficacy and safety of the combination of single doses of ivermectin and diethylcarbamazine.
Shenoy RK; George LM; John A; Suma TK; Kumaraswami V
Ann Trop Med Parasitol; 1998 Jul; 92(5):579-85. PubMed ID: 9797831
[TBL] [Abstract][Full Text] [Related]
26. Filarial vector studies in a diethylcarbamazine-treated and in untreated villages in Papua New Guinea.
Bryan JH; Dagoro H; Southgate BA
J Trop Med Hyg; 1995 Dec; 98(6):445-51. PubMed ID: 8544229
[TBL] [Abstract][Full Text] [Related]
27. Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia--a longitudinal study.
Sunish IP; Rajendran R; Mani TR; Munirathinam A; Tewari SC; Hiriyan J; Gajanana A; Satyanarayana K
Trop Med Int Health; 2002 Jan; 7(1):59-69. PubMed ID: 11851956
[TBL] [Abstract][Full Text] [Related]
28. Can vector control play a useful supplementary role against bancroftian filariasis?
Maxwell CA; Mohammed K; Kisumku U; Curtis CF
Bull World Health Organ; 1999; 77(2):138-43. PubMed ID: 10083712
[TBL] [Abstract][Full Text] [Related]
29. Antigenemia at 10 years after diethylcarbamazine treatment of asymptomatic microfilaraemic individuals: marginal conversion to infection-free state.
Beuria MK; Bal MS; Mandal NN; Das MK
Parasite Immunol; 2002 Feb; 24(2):109-11. PubMed ID: 11874566
[TBL] [Abstract][Full Text] [Related]
30. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis.
Freedman DO; Plier DA; De Almeida AB; De Oliveira AL; Miranda J; Braga C
Trop Med Int Health; 2001 Jan; 6(1):37-41. PubMed ID: 11251894
[TBL] [Abstract][Full Text] [Related]
31. Microfilaraemia, serum antibody and development of clinical disease in microfilaraemic subjects infected with Wuchereria bancrofti and treated with diethylcarbamazine citrate.
Dissanayake S
Trans R Soc Trop Med Hyg; 1989; 83(3):384-8. PubMed ID: 2694470
[TBL] [Abstract][Full Text] [Related]
32. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments.
Meyrowitsch DW; Simonsen PE; Makunde WH
Trans R Soc Trop Med Hyg; 1996; 90(1):69-73. PubMed ID: 8730317
[TBL] [Abstract][Full Text] [Related]
33. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt.
Meyrowitsch DW; Simonsen PE; Makunde WH
Trans R Soc Trop Med Hyg; 1996; 90(1):74-9. PubMed ID: 8730318
[TBL] [Abstract][Full Text] [Related]
34. Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies.
Helmy H; Weil GJ; Ellethy AS; Ahmed ES; Setouhy ME; Ramzy RM
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):656-62. PubMed ID: 16414095
[TBL] [Abstract][Full Text] [Related]
35. Bancroftian filariasis: clinical parasitologic and serologic evaluation after 4 years applying two antifilarial regimens.
Abdul-Fattah MM; El-Karamany EM; El-Gindy AM; Nimr WA; El-Shamy MH
J Egypt Soc Parasitol; 2002 Dec; 32(3):849-53. PubMed ID: 12512817
[TBL] [Abstract][Full Text] [Related]
36. Duration of diethylcarbamazine treatment and clearance of microfilaraemia in bancroftian filariasis.
Sethumadhavan KV; Ravindranathan TC; Babu CS; Roychowdhury SP; Narasimham MV; Kanoujia KH; Sharma SP; Rao CK
J Commun Dis; 1980 Mar; 12(1):34-8. PubMed ID: 7005315
[No Abstract] [Full Text] [Related]
37. [Effect of diethylcarbamazine as a provocation test in Wuchereria bancrofti filariasis].
Lastre González M; Pérez Avila J; Cordoví Prado R
Rev Cubana Med Trop; 1982; 34(3):253-62. PubMed ID: 6764268
[No Abstract] [Full Text] [Related]
38. Persistence of microfilaremia in bancroftian filariasis after diethylcarbamazine citrate therapy.
Eberhard ML; Lowrie RC; Lammie PJ
Trop Med Parasitol; 1988 Jun; 39(2):128-30. PubMed ID: 3051291
[TBL] [Abstract][Full Text] [Related]
39. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations.
Shenoy RK; John A; Babu BS; Suma TK; Kumaraswami V
Ann Trop Med Parasitol; 2000 Sep; 94(6):607-14. PubMed ID: 11064762
[TBL] [Abstract][Full Text] [Related]
40. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
Rizzo JA; Belo C; Lins R; Dreyer G
Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
